Position in JNJ
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$9,645,272
-$358,190 QoQ
Shares Held
37,978
-7.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.91%
of 13F equity value
Holder Rank
#1,136
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Wealthcare Advisory Partners LLC holds $56,868,613 across 12 Drug Manufacturers - General names. JNJ ranks #3 (17.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
50,422 | $12,688,192 | |
| 2 | LLY |
ELI LILLY & Co
|
10,304 | $12,358,927 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
37,978 | $9,645,272 | |
| 4 | AMGN |
Amgen Inc
|
15,360 | $5,562,163 | |
| 5 | MRK |
Merck & Co., Inc.
|
34,872 | $4,481,052 | |
| 6 | PFE |
Pfizer Inc
|
147,571 | $3,553,509 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
19,347 | $2,444,299 | |
| 8 | AZN |
Astrazeneca PLC
|
12,112 | $2,296,677 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,645,272 | 37,978 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $10,003,462 | 40,924 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $15,558,501 | 75,180 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $13,404,011 | 72,290 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $10,914,293 | 71,452 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $11,783,927 | 71,056 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $10,463,257 | 72,350 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $12,424,329 | 76,665 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $11,186,355 | 76,535 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $11,815,369 | 74,691 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $11,203,931 | 71,481 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $11,519,893 | 73,964 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $12,924,463 | 78,084 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $12,401,550 | 80,010 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $14,136,592 | 80,026 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $12,640,143 | 77,376 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $12,457,651 | 70,180 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $11,083,078 | 62,535 | Shares | Sole | 2022-04-15 | |
| 2021-12-31 | $10,566,993 | 61,770 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $9,933,542 | 61,508 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $9,994,446 | 60,668 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $9,941,038 | 60,487 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $8,897,635 | 56,536 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $7,421,072 | 49,846 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $6,779,772 | 48,210 | Shares | Sole | 2020-07-29 | |
| 2020-03-31 | $6,244,672 | 47,622 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||